{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T17:07:15Z","timestamp":1697735235443},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00228-018-2577-3","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T05:37:24Z","timestamp":1539581844000},"page":"189-194","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Response to sertraline is influenced by GN\u03b23 gene G-350A variant in patients with major depressive disorder"],"prefix":"10.1007","volume":"75","author":[{"given":"Dena","family":"Firouzabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Firouzabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiana","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamyar","family":"Zomorrodian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham Shirazi","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"issue":"6042","key":"2577_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1126\/science.1205295","volume":"333","author":"RS Ray","year":"2011","unstructured":"Ray RS, Corcoran AE, Brust RD, Kim JC, Richerson GB, Nattie E, Dymecki SM (2011) Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition. Science 333(6042):637\u2013642","journal-title":"Science"},{"key":"2577_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355\u2013366","journal-title":"Annu Rev Med"},{"issue":"12","key":"2577_CR3","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1172\/JCI70678","volume":"123","author":"HY Meltzer","year":"2013","unstructured":"Meltzer HY, Roth BL (2013) Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype\u2013targeted drugs. J Clin Invest 123(12):4986\u20134991","journal-title":"J Clin Invest"},{"issue":"S350","key":"2577_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1600-0447.1989.tb07188.x","volume":"80","author":"K Rickels","year":"1989","unstructured":"Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C (1989) A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients. Acta Psychiatr Scand 80(S350):117\u2013123","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"2577_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1600-0447.1990.tb06476.x","volume":"81","author":"D Laws","year":"1990","unstructured":"Laws D, Ashford J, Anstee J (1990) A multicentre double-blind comparative trial of fluvoxamine versus lorazepam in mixed anxiety and depression treated in general practice. Acta Psychiatr Scand 81(2):185\u2013189","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"2577_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1001\/jama.280.8.708","volume":"280","author":"MB Stein","year":"1998","unstructured":"Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I (1998) Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. Jama 280(8):708\u2013713","journal-title":"Jama"},{"issue":"1","key":"2577_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/archpsyc.1989.01810010038006","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS (1989) Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 46(1):36\u201344","journal-title":"Arch Gen Psychiatry"},{"key":"2577_CR8","unstructured":"van der Kolk B, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G (1994) Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 5(12):517\u2013522"},{"issue":"5","key":"2577_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1600-0447.1997.tb09660.x","volume":"95","author":"P Rocca","year":"1997","unstructured":"Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L (1997) Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 95(5):444\u2013450","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"2577_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00004714-199802000-00003","volume":"18","author":"RD Marshall","year":"1998","unstructured":"Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D, Campeas R, Liebowitz MR (1998) An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. J Clin Psychopharmacol 18(1):10\u201318","journal-title":"J Clin Psychopharmacol"},{"key":"2577_CR11","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/S0924-977X(99)00030-9","volume":"9","author":"DJ Nutt","year":"1999","unstructured":"Nutt DJ, Forshall S, Bell C, Rich A, Sandford J, Nash J, Argyropoulos S (1999) Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. Eur Neuropsychopharmacol 9:S81\u2013S86","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"2577_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0361-9230(01)00623-2","volume":"56","author":"JA Gray","year":"2001","unstructured":"Gray JA, Roth BL (2001) Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists. Brain Res Bull 56(5):441\u2013451","journal-title":"Brain Res Bull"},{"issue":"7","key":"2577_CR13","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1074\/jbc.R400030200","volume":"280","author":"BN Armbruster","year":"2005","unstructured":"Armbruster BN, Roth BL (2005) Mining the receptorome. J Biol Chem 280(7):5129\u20135132","journal-title":"J Biol Chem"},{"issue":"2","key":"2577_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0304-4157(90)90007-Y","volume":"1031","author":"L Birnbaumer","year":"1990","unstructured":"Birnbaumer L, Abramowitz J, Brown AM (1990) Receptor-effector coupling by G proteins. Biochim Biophys Acta Rev Biomembr 1031(2):163\u2013224","journal-title":"Biochim Biophys Acta Rev Biomembr"},{"issue":"1","key":"2577_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.bi.56.070187.003151","volume":"56","author":"AG Gilman","year":"1987","unstructured":"Gilman AG (1987) G proteins: transducers of receptor-generated signals. Annu Rev Biochem 56(1):615\u2013649","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"2577_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1258\/0007142001903535","volume":"56","author":"JM Drazen","year":"2000","unstructured":"Drazen JM, Silverman EK, Lee TH (2000) Heterogeneity of therapeutic responses in asthma. Br Med Bull 56(4):1054\u20131070","journal-title":"Br Med Bull"},{"issue":"9","key":"2577_CR17","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1097\/00001756-200006260-00018","volume":"11","author":"P Zill","year":"2000","unstructured":"Zill P, Baghai TC, Zwanzger P, Sch\u00fcle C, Minov C, Riedel M, Neumeier K, Rupprecht R, Bondy B (2000) Evidence for an association between a G-protein \u03b23-gene variant with depression and response to antidepressant treatment. Neuroreport 11(9):1893\u20131897","journal-title":"Neuroreport"},{"issue":"4","key":"2577_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1208\/ps050429","volume":"5","author":"J Pinsonneault","year":"2003","unstructured":"Pinsonneault J, Sad\u00e9e W (2003) Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome. AAPS PharmSci 5(4):49\u201361","journal-title":"AAPS PharmSci"},{"issue":"1","key":"2577_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1527-3458.2001.tb00188.x","volume":"7","author":"G MacQueen","year":"2001","unstructured":"MacQueen G, Born L, Steiner M (2001) The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Rev 7(1):1\u201324","journal-title":"CNS Drug Rev"},{"key":"2577_CR20","doi-asserted-by":"crossref","unstructured":"Richelson E (1994) Pharmacology of antidepressants\u2014characteristics of the ideal drug. In: Mayo Clinic Proceedings ed. Elsevier, pp 1069\u20131081","DOI":"10.1016\/S0025-6196(12)61375-5"},{"key":"2577_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18433\/J3W31F","volume":"20","author":"N Firouzabadi","year":"2017","unstructured":"Firouzabadi N, Raeesi R, Zomorrodian K, Bahramali E, Yavarian I (2017) Beta adrenoceptor polymorphism and clinical response to sertraline in major depressive patients. J Pharm Pharm Sci 20:1\u20137","journal-title":"J Pharm Pharm Sci"},{"issue":"6","key":"2577_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1600-0447.1998.tb10117.x","volume":"98","author":"A Serretti","year":"1998","unstructured":"Serretti A, Franchini L, Gasperini M, Rampoldi R, Smeraldi E (1998) Mode of inheritance in mood disorder families according to fluvoxamine response. Acta Psychiatr Scand 98(6):443\u2013450","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"2577_CR23","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"S Miller","year":"1988","unstructured":"Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2577_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/01.HYP.36.1.33","volume":"36","author":"D Rosskopf","year":"2000","unstructured":"Rosskopf D, Busch S, Manthey I, Siffert W (2000) G protein \u03b23 gene: structure, promoter, and additional polymorphisms. Hypertension 36(1):33\u201341","journal-title":"Hypertension"},{"issue":"9","key":"2577_CR25","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1185\/030079906X132415","volume":"22","author":"M Machado","year":"2006","unstructured":"Machado M, Iskedjian M, Ruiz I, Einarson TR (2006) Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Curr Med Res Opin 22(9):1825\u20131837","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2577_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice. Am J Psychiatr 163(1):28\u201340","journal-title":"Am J Psychiatr"},{"issue":"5","key":"2577_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0022-3956(98)00004-1","volume":"32","author":"L Franchini","year":"1998","unstructured":"Franchini L, Serretti A, Gasperini M, Smeraldi E (1998) Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees. J Psychiatr Res 32(5):255\u2013259","journal-title":"J Psychiatr Res"},{"key":"2577_CR28","doi-asserted-by":"crossref","unstructured":"Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, Roots I, Sasse J, Brockm\u00f6ller J (2008) Genetic variants in FKBP5 affecting response to antidepressant drug treatment Future Medicine 9(7):1\u2013\u20137","DOI":"10.2217\/14622416.9.7.841"},{"issue":"1","key":"2577_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00406-007-1004-z","volume":"258","author":"W Maier","year":"2008","unstructured":"Maier W, Zobel A (2008) Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics. Eur Arch Psychiatry Clin Neurosci 258(1):12\u201320","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"2577_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1017\/S1461145703003663","volume":"6","author":"PR Joyce","year":"2003","unstructured":"Joyce PR, Mulder RT, Luty SE, McKenzie JM, Miller AL, Rogers GR, Kennedy MA (2003) Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein \u03b2 3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol 6(4):339\u2013346","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"2577_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0924-977X(02)00154-2","volume":"13","author":"A Serretti","year":"2003","unstructured":"Serretti A, Lorenzi C, Cusin C, Zanardi R, Lattuada E, Rossini D, Lilli R, Pirovano A, Catalano M, Smeraldi E (2003) SSRIs antidepressant activity is influenced by G\u03b23 variants. Eur Neuropsychopharmacol 13(2):117\u2013122","journal-title":"Eur Neuropsychopharmacol"},{"issue":"9","key":"2577_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/FPC.0b013e3283491153","volume":"21","author":"S Klenke","year":"2011","unstructured":"Klenke S, Kussmann M, Siffert W (2011) The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics 21(9):594\u2013606","journal-title":"Pharmacogenet Genomics"},{"issue":"3","key":"2577_CR33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1471-4159.1999.0731121.x","volume":"73","author":"D Dowlatshahi","year":"1999","unstructured":"Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT (1999) G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders. J Neurochem 73(3):1121\u20131126","journal-title":"J Neurochem"},{"issue":"4","key":"2577_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1176\/ajp.151.4.594","volume":"151","author":"LT Young","year":"1994","unstructured":"Young LT, Li PP, Kamble A, Siu KP, Warsh JJ (1994) Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am J Psychiatry 151(4):594\u2013596","journal-title":"Am J Psychiatry"},{"issue":"9","key":"2577_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0006-3223(95)00248-0","volume":"39","author":"S Avissar","year":"1996","unstructured":"Avissar S, Barki-Harrington L, Nechamkin Y, Roitman G, Schreiber G (1996) Reduced \u03b2-adrenergic receptor-coupled Gs protein function and Gs\u03b1 immunoreactivity in mononuclear leukocytes of patients with depression. Biol Psychiatry 39(9):755\u2013760","journal-title":"Biol Psychiatry"},{"key":"2577_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jad.2014.04.044","volume":"165","author":"CA Bousman","year":"2014","unstructured":"Bousman CA, Potiriadis M, Everall IP, Gunn JM (2014) G-protein \u03b23 subunit genetic variation moderates five-year depressive symptom trajectories of primary care attendees. J Affect Disord 165:64\u201368","journal-title":"J Affect Disord"},{"issue":"5","key":"2577_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.euroneuro.2005.02.001","volume":"15","author":"DJ M\u00fcller","year":"2005","unstructured":"M\u00fcller DJ, De Luca V, Sicard T, King N, Hwang R, Volavka J, Czobor P, Sheitman BB, Lindenmayer J-P, Citrome L (2005) Suggestive association between the C825T polymorphism of the G-protein \u03b23 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. Eur Neuropsychopharmacol 15(5):525\u2013531","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"2577_CR38","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.pnpbp.2008.01.019","volume":"32","author":"M Kato","year":"2008","unstructured":"Kato M, Wakeno M, Okugawa G, Fukuda T, Takekita Y, Hosoi Y, Azuma J, Kinoshita T, Serretti A (2008) Antidepressant response and intolerance to SSRI is not influenced by G-protein \u03b23 subunit gene C825T polymorphism in Japanese major depressive patients. Prog Neuro-Psychopharmacol Biol Psychiatry 32(4):1041\u20131044","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"7","key":"2577_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0006-3223(03)00169-0","volume":"54","author":"M Willeit","year":"2003","unstructured":"Willeit M, Praschak-Rieder N, Zill P, Neumeister A, Ackenheil M, Kasper S, Bondy B (2003) C825T polymorphism in the G protein \u03b23-subunit gene is associated with seasonal affective disorder. Biol Psychiatry 54(7):682\u2013686","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2577_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng0198-45","volume":"18","author":"W Siffert","year":"1998","unstructured":"Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann H-E, Jakobs KH (1998) Association of a human G-protein \u03b23 subunit variant with hypertension. Nat Genet 18(1):45\u201348","journal-title":"Nat Genet"},{"issue":"5","key":"2577_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4088\/JCP.v60n0511","volume":"60","author":"RM Hirschfeld","year":"1999","unstructured":"Hirschfeld RM (1999) Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. J Clin Psychiatry 60(5):326\u2013335","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"2577_CR42","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4088\/JCP.v61n1209","volume":"61","author":"RA Suri","year":"2000","unstructured":"Suri RA, Altshuler LL, Rasgon NL, Calcagno JL, Frye MA, Gitlin MJ, Hwang S, Zuckerbrow-Miller J (2000) Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder. J Clin Psychiatry 61(12):942\u2013946","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2577_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1741-7015-11-132","volume":"11","author":"U Ozomaro","year":"2013","unstructured":"Ozomaro U, Wahlestedt C, Nemeroff CB (2013) Personalized medicine in psychiatry: problems and promises. BMC Med 11(1):132","journal-title":"BMC Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-2577-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-2577-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T19:05:26Z","timestamp":1571079926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-2577-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2577"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-2577-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"14 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the local committee for ethics of medical experiments on human subjects of Shiraz University of Medical Sciences and carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) and Uniform Requirements for manuscripts submitted to biomedical journals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}